tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
AQST
Aquestive Therapeutics
RESEARCH TOOLSreports

Aquestive Therapeutics (AQST) Income Statement

2,469 Followers

Aquestive Therapeutics Income Statement

Last quarter (Q4 2025), Aquestive Therapeutics's total revenue was $13.02M, an increase of 9.67% from the same quarter last year. In Q4, Aquestive Therapeutics's net income was $-31.86M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 44.55M$ 57.56M$ 50.58M$ 47.68M$ 50.83M
Gross Profit
$ 25.99M$ 39.69M$ 29.75M$ 28.29M$ 35.84M
Operating Expenses
$ 97.04M$ 70.46M$ 44.85M$ 70.36M$ 70.52M
Depreciation and Amortization
$ 559.00K$ 718.00K$ 1.34M$ 2.39M$ 2.96M
EBITDA
$ -70.49M$ -26.62M$ 1.18M$ -39.58M$ -45.11M
Operating Income
$ -71.05M$ -30.77M$ -15.10M$ -42.07M$ -34.68M
Other Income/Expenses
$ -12.73M$ -13.38M$ 7.48M$ -12.34M$ -35.86M
Pretax Income
$ -83.78M$ -44.15M$ -7.63M$ -54.41M$ -70.54M
Net Income
$ -83.78M$ -44.14M$ -7.87M$ -54.41M$ -70.54M
Per Share Metrics
Basic EPS
$ -0.76$ -0.51$ -0.13$ -1.12$ -1.85
Diluted EPS
$ -0.76$ -0.51$ -0.13$ -1.12$ -1.85
Weighted Average Shares Outstanding
 121.97M 86.73M 61.26M 48.73M 38.08M
Weighted Average Shares Outstanding (Diluted)
 121.97M 86.73M 61.26M 48.73M 38.08M
Currency in USD

Aquestive Therapeutics Earnings and Revenue History